The text starts here.

News Release

July 27, 2007
For Print (PDF 137KB)

Eisai Co-promotes “PyloriTek® Test Kit”,
H. Pylori Infection Diagnostic Kit Launched by Sanko Junyaku

Sanko Junyaku Co., Ltd.
Eisai Co., Ltd.

Sanko Junyaku Co., Ltd. (Headquarters: Tokyo, President: Masao Jimbo) today announced that it will launch the PyloriTek® Test Kit, a diagnostic kit for detecting Helicobacter pylori (H. pylori) infection in gastric biopsy specimens. The PyloriTek® Test Kit will be introduced to the market by Sanko Junyaku in September 2007 in co-promotion with its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito)

H. pylori is a type of bacterium in the human stomach and has been known to be deeply associated with peptic ulcers. The H. pylori eradication therapy has shown efficacy in reducing the risk for ulcer recurrence, providing a great benefit for patients.

The PyloriTek® Test Kit is a diagnostic product used in the presumptive identification of H. pylori infection before and after the eradication therapy to evaluate infectious status of the patients. The PyloriTek® Test Kit shortens the diagnostic testing procedures due to the simplified preparation, enabling the test to start at the earliest opportunity. In addition, easier result evaluation can be made possible by the large reaction pad on which a positive reaction appears as an intense color change.

Eisai Group established the Japan Business Headquarters in April 2007 which facilitates provision of information, services and products under the business strategy unified by all four domestic operations of Eisai Group (diagnostics/prescription pharmaceuticals/consumer healthcare products/generics). Eisai Co., Ltd. which co-promotes the PyloriTek® Test Kit has been marketing Pariet® (generic name: rabeprazole sodium), the company’s core proton pump inhibitor which is approved for H. pylori eradication therapy in combination with antibiotics.

From diagnostics to treatment, Sanko Junyaku and Eisai provide a wide range of products and information for H. pylori infection, thereby making further contributions to the treatment of acid related disorders and improve the QOL (Quality of Life) of patients with peptic ulcers.

[Please see the following notes for the PyloriTek® Test Kit product information, the corporate profiles and product image]

Kazunori Nishina
Investor Relations,
Sanko Junyaku Co., Ltd.
TEL: 81-3-3865-4311
Corporate Communications Department,
Eisai Co., Ltd.
TEL: 81-3-3817-5120

< Note to Editor >

Product Outline of PyloriTek® Test Kit

Name of the Product:  PyloriTek® Test Kit (Helicobacter Pylori Urease Kit)
Intended Use:  Detecting H. Pylori infection in gastric biopsy specimens
Shelf Life:  2 years after the manufacturing date (stored at 2 - 8°C)
NHI Insurance Point  (as of July, 2007):
  Sample Testing Fee: 60 points per immunologic test for infectious disease
  (Rapid urease test)
  Biopsy diagnosing fee: 144 points per evaluation of immunologic test
Delivery Price:  12,900 yen / package containing 25 test strips
Manufactured by:  Serim Research Corp. (U.S.A.)
Manufactured and marketed by:  Sakura Finetek Japan Co., Ltd.
Marketed by:  Sanko Junyaku Co., Ltd.
Co-promotion with:  Eisai Co., Ltd.

Corporate Profiles

Sanko Junyaku Co., Ltd.
RepresentativeMasao Jimbo
Location of headquarters1-10-6 Iwamoto-cho, Chiyoda-ku, Tokyo, Japan
OperationsManufacturing, marketing and import of in vitro diagnostics, laboratory reagents, laboratory instruments, etc.
Capital5,262 million yen (50.59% owned by Eisai, as of March 31, 2007)

Eisai Co., Ltd.
RepresentativeHaruo Naito
Location of headquarters4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan
OperationsResearch & development, manufacturing, marketing and export and import of pharmaceuticals.
Capital44,985 million yen (as of March 31, 2007)

Product Image
PyloriTek(R) Test Kit